Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients
Eva Boysen Fynboe Ebert, Tine McCulloch, Karin Holmskov Hansen, Hanne Linnet, Boe Sandahl Sørensen, Peter Meldgaard
Topics & Concepts
OsimertinibMedicineLung cancerCirculating tumor DNAOncologyCancer researchInternal medicineCancerEpidermal growth factor receptorErlotinibLung Cancer Treatments and MutationsLung Cancer Research StudiesCancer Genomics and Diagnostics